FdaApplication
NDA 214154
Identifiers
- fda_app_no: NDA214154
Properties
| Property | Value |
|---|---|
| applicant_name | MAYNE PHARMA LLC |
| application_type | NDA |
| approval_date | 2021-04-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXTSTELLIS | DROSPIRENONE; ESTETROL | 3MG;14.2MG | TABLET;ORAL |
1 product